Buy Brand name Tivicay from Europe and save up to 42% and generic Tivicay today and save over 85% vs brand name US prices.
Click here for information on Mylan generics (Immediate availability)
Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.
According to the European Medicines Agency, brand name Tivicay originating from Europe is manufactured at the following site(s):Glaxo Wellcome, S.A., Avda. Extremadura 3, 09400 Aranda De Duero, Burgos, Spain
Prescription Tivicay contains dolutegravir, an antiretroviral medicine classified as an integrase inhibitor (INIs). Tivicay is a treatment for HIV-1 in adults and children over 6 years of age (over 33 pounds). Tivicay is most often used in combination with other HIV medicines. Tivicay is not a cure but is used to reduce the amount of HIV virus in the body and keep its level low.
Your physician will monitor the effectiveness of Tivicay in each case.
Tivicay is taken with or without food once or twice per day depending upon your physicians prescription. Tivicay is taken with water or other liquid as one single tablet.
Tivicay is approved in more than 100 countries worldwide and has a good safety record.
Buy Tivicay from InsulinHub.com for the best Tivicay cost.
Information about Tivicay (Dolutegravir)
Tivicay is a prescription medication that contains dolutegravir, an antiretroviral drug used to treat HIV (human immunodeficiency virus) infection. It belongs to a class of medications called integrase strand transfer inhibitors (INSTIs), which work by inhibiting the integrase enzyme, a key enzyme that the HIV virus uses to insert its genetic material into the host's DNA. By blocking this process, Tivicay helps prevent the replication of the HIV virus.
Product Highlights
- Tivicay is used as part of a combination antiretroviral regimen to treat HIV-1 infection in both treatment-naive and treatment-experienced adults and pediatric patients.
- When used with other medications, Tivicay can help reduce the risk of HIV transmission by lowering viral load to undetectable levels.
Key Ingredient
Key Benefits
- Tivicay is highly effective in reducing viral load and maintaining undetectable levels of HIV in the blood.
- It offers the convenience of once-daily dosing, improving adherence to HIV treatment regimens.
- Dolutegravir is generally well-tolerated, with a relatively favorable side effect profile compared to other HIV medications.
- When used properly as part of a combination regimen, Tivicay has a low risk of developing resistance.
Direction of Use
- Tivicay is typically taken once a day, with or without food.
- Take the prescribed dose of Tivicay by mouth, swallowing the tablet whole.
- Tivicay is usually prescribed as part of a combination therapy, so be sure to follow your doctor’s instructions and take other prescribed medications along with Tivicay.
- Try to take your dose at the same time every day to maintain consistency and improve treatment effectiveness.
Safety Concerns
- Tivicay can interact with other medications, including certain antacids, proton pump inhibitors (PPIs), and other HIV medications. Always inform your doctor of all medications and supplements you are taking.
- People with liver problems should use Tivicay with caution, as it may affect liver function. Regular monitoring of liver enzymes may be necessary.
- Common side effects include headache, diarrhea, insomnia, and fatigue. Serious side effects, although rare, can include liver toxicity, severe skin reactions, and allergic reactions.
Avoid Tivicay (Dolutegravir) If
- You are allergic to dolutegravir or any other ingredient in Tivicay.
- You are taking certain medications that are contraindicated with Tivicay, such as dofetilide, a medication used for heart rhythm disorders.
- You have severe liver problems or liver disease (consult your doctor for alternatives).
- You are pregnant or planning to become pregnant. Dolutegravir should only be used in pregnancy when the benefits outweigh the risks, and a healthcare provider should carefully assess this.
